Overexpression of constitutively active Akt significantly reverses the inhibitory effects of propofol in K562, confirm that propofol acts on CML cells via inhibition of Akt/mTOR. This evidence concerns the gene MTOR and chronic myelogenous leukemia, BCR-ABL1 positive.